Day: December 1, 2025

Stress Management for Leaders: A Critical Competency in Modern Leadership

In today’s volatile business environment, leaders must think fast, stay resilient, and make high-stakes decisions with clarity. Stress is no…

Read More »

Hot Jobs Of The Week 01 – 07.12.2025

Read More »

Stroke: Pathophysiology – Epidemiology – Emergency Management & Prevention

Abstract Stroke, including ischemic and hemorrhagic types, remains the second leading cause of death and a major cause of long-term…

Read More »

Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval

The U.S. Food and Drug Administration (USFDA) has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of adults…

Read More »

Generic Drug Approval Secured for Type 2 Diabetes Treatment in the US

A pharmaceutical company has announced that it secured tentative approval from the United States Food and Drug Administration (USFDA) for…

Read More »

Major Pharmaceutical Group Acquires Preclinical Cancer Asset

In light of substantial recent investments in oncology and mounting competition, a leading pharmaceutical corporation is seeking a new approach…

Read More »

Novel Immunotherapy Regimen Approved for Early-Stage Gastric Cancer

The U.S. Food and Drug Administration (FDA) has granted approval for the use of Durvalumab (an immunotherapy) in combination with…

Read More »

Expedited Review Sought for New Higher-Dose Obesity Treatment

A pharmaceutical corporation has submitted a supplemental application for a higher dose semaglutide injectable (7.2 mg) to the U.S. Food…

Read More »

Global Strategic Restructuring: A Major Pharma Group’s Shift Toward Automation and Production Reallocation

The recent decisions by a leading Swiss pharmaceutical group highlight a broader trend within the industry: prioritizing automation, advanced manufacturing…

Read More »

Cost-Effective Solution for Retinal Diseases Enters European Market

On November 24, 2025, in Basel, Sandoz, a global leader in affordable medicines, announced the European launch of Afqlir® (aflibercept).…

Read More »

Investigating Antibiotic Strategies to Address a Global Health Challenge

Antimicrobial Resistance (AMR) is emerging as a critical worldwide public health threat, with the potential to cause at least 10…

Read More »

HCMC University Medical Centre and Novartis Strengthen Medical Collaboration

On November 19, in Ho Chi Minh City, the University Medical Centre of Hồ Chí Minh City (UMC) and Novartis…

Read More »

Vietnam’s Healthcare Sector on the Verge of a Breakthrough: Expectations for Digital Transformation

At the 23rd Annual Scientific Conference of the Southern Region Hospital Directors Club, delegates focused their discussions on digital transformation,…

Read More »

Da Nang Possesses Great Potential to Become a Medical Tourism Hub

Da Nang is assessed as a locality with significant advantages for developing medical tourism. Mr. Tran Quoc Bao, Senior Advisor…

Read More »

Vietnam Implements Hepatitis D Screening for the First Time to Global Standards

A crucial study regarding Hepatitis Delta Virus (HDV), titled HEP-D, is being executed in Vietnam, adhering to international standards. HDV…

Read More »

Dental System Leads Ho Chi Minh City Department of Health’s 15-Criteria Ranking

The Ho Chi Minh City Department of Health (Ho Chi Minh City DoH) has announced the results of its dental…

Read More »

Proposal to Add 76 New Drugs to Health Insurance Coverage List

The Ministry of Health is proposing to add 76 new drugs to the list covered by Health Insurance (BHYT). This…

Read More »

Sandoz Launches New Biosimilar Option in Europe

The Sandoz group has officially introduced Afqlir, its biosimilar referencing aflibercept, across various European markets. The drug received approval from…

Read More »

US Regulator Approves Spinal Gene Therapy

The U.S. Food and Drug Administration (FDA) has approved the intrathecal (spinal injection) formulation of the gene therapy onasemnogene abeparvovec,…

Read More »

Pharmaceutical Giant Commits Major U.S. Manufacturing Investment

The pharmaceutical corporation AstraZeneca announced a plan to invest $2 billion to expand its production capabilities within the state of…

Read More »